FeesSafety
Pluang+

MasterCraft beats Q4 estimates with $129.94M revenue, boosted by Marine Products acquisition.

Company Fundamentals
15 Sep 2026
Alex Lavoie
View Source
Bullish
MasterCraft beats Q4 estimates with $129.94M revenue, boosted by Marine Products acquisition.

MasterCraft Boat Holdings reported fiscal Q4 2026 adjusted earnings of $0.67 per share and revenue of $129.94 million, surpassing estimates. Revenue growth was driven by its Performance and Wake business and the Marine Products acquisition, which added $33.3 million in sales. Despite adjusted profits, GAAP results showed a loss due to acquisition costs and a non-cash impairment charge. The company expects net sales of $287-$291 million and adjusted earnings of $0.66-$0.76 per share for the next six-month transition period ending December 31, 2026.

MasterCraft's recent earnings report provides context for market watchers. For readers following consumer cyclical stocks, here is Pluang's market snapshot as of Sep 15, 2026 23:51 WIB: Out of 105 priced US stocks, 17 rose and 87 fell. Notable price changes include CMG at USD 34.71 (-6.25%), TDUP at USD 2.55 (-5.94%), and BBWI at USD 16.86 (-5.86%).

More News

Remittix raises $33M, burns 300M RTX tokens, as XRP Ledger update sparks $10 XRP price talk

Remittix raises $33M, burns 300M RTX tokens, as XRP Ledger update sparks $10 XRP price talk

Remittix has raised $33 million and will burn 300 million RTX tokens, reducing supply by 20% ahead of public trading starting November 24, 2026. This token burn and near-cap funding boost scarcity and investor interest. Meanwhile, the XRP Ledger's No...

Market News
Bullish
3 hours ago
XTransfer debuts at Money20/20 USA to boost cross-border B2B payments in Latin America.

XTransfer debuts at Money20/20 USA to boost cross-border B2B payments in Latin America.

XTransfer, a leading global B2B cross-border payment platform, made its first appearance at Money20/20 USA 2026 in Las Vegas to accelerate its expansion into Latin American markets. The company recently completed regulatory registration in Chile, ena...

Market News
Bullish
3 hours ago
Lunit and Summit Therapeutics partner to use AI for tumor analysis in cancer drug development

Lunit and Summit Therapeutics partner to use AI for tumor analysis in cancer drug development

Lunit Inc. and Summit Therapeutics have entered a research agreement to use Lunit's AI-powered pathology platform, Lunit SCOPE IO, for analyzing tumor microenvironments in support of Summit's immuno-oncology drug ivonescimab. The AI platform will ana...

Market News
Bullish
4 hours ago
Virtuals Protocol tests automated options trading for BTC and ETH hedging around US economic data.

Virtuals Protocol tests automated options trading for BTC and ETH hedging around US economic data.

Virtuals Protocol is conducting a private test of Butler's automated options trading on the Derive platform, allowing Bitcoin and Ether holders to hedge against major U.S. economic events like Federal Reserve rate decisions and CPI releases. Users se...

Protocol Fundamentals
Neutral
4 hours ago
Crypto markets face volatility around Nov 3 U.S. midterms; policy shifts unlikely to spark sustained rally.

Crypto markets face volatility around Nov 3 U.S. midterms; policy shifts unlikely to spark sustained rally.

HTX Research forecasts choppy crypto trading before and after the Nov. 3 U.S. midterm elections, noting that changes in congressional control may alter policy expectations but won't alone drive a lasting market rally. Near-term crypto prices are more...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App